Hydrogen Research Study
← Back to Research Library
Preclinical animal evidenceAnimal studyOther or not reported

Preservative effect of electrolyzed reduced water on pancreatic beta-cell mass in diabetic db/db mice.

Mi-Ja Kim, Kyung Hee Jung, Yoon Kyung Uhm, Kang-Hyun Leem, Hye Kyung Kim · Biological & pharmaceutical bulletin · 2007

Research-use notice

Independent study record

Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.

H2HUBB Research Library branded molecular hydrogen research image
Primary topic Diabetes and Metabolic Health
Evidence type Preclinical animal evidence
Publication type Animal study
Hydrogen method Other or not reported

H2HUBB TAKEAWAY

In mice, electrolyzed reduced water (ER W) exhibits high pH (pH 10—12), low dissolved oxygen (1.3—3.5 mg/l), high dissolved hydrogen (0.3—0.6 mg/l), and significant negative redox potential ( /H11002400— /H11002900 mV). These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.

What the Findings Mean

H2HUBB reviewed how molecular hydrogen affected the outcomes measured in mice. Electrolyzed reduced water (ER W) exhibits high pH (pH 10—12), low dissolved oxygen (1.3—3.5 mg/l), high dissolved hydrogen (0.3—0.6 mg/l), and significant negative redox potential ( /H11002400— /H11002900 mV).

What the Researchers Studied

The researchers studied mice. The study used a preclinical animal experiment. The comparison condition was control condition or baseline measurements.

What Effects Did Molecular Hydrogen Have?

Electrolyzed reduced water (ER W) exhibits high pH (pH 10—12), low dissolved oxygen (1.3—3.5 mg/l), high dissolved hydrogen (0.3—0.6 mg/l), and significant negative redox potential ( /H11002400— /H11002900 mV). The authors concluded that the present data suggest that ERW may protects beta-cell damage and would be useful for antidiabetic agent.

Why These Findings Matter

These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.

How Strong Is This Evidence?

This is preclinical animal evidence from a preclinical animal experiment. It is most informative for the disease model, mechanisms, biomarkers, and outcomes directly measured in the study.

Technical Study Details

H2HUBB classifies this publication as animal study with preclinical animal evidence. The research population or model was mice. The study used a preclinical animal experiment.

Limitations and Safety

No separate limitations or safety findings were identified in the source text available to H2HUBB.

Original Study and H2HUBB Research Context

H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base. The original scholarly source is available at https://www.jstage.jst.go.jp/article/bpb/30/2/30_2_234/_pdf.